Health Care & Life Sciences » Pharmaceuticals | MPH Mittelstaendische Pharma Holding AG

MPH Mittelstaendische Pharma Holding AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
226,844.30
219,248.60
262,886.60
47.30
66.40
Cost of Goods Sold (COGS) incl. D&A
217,538.30
205,767.40
248,239.30
566.10
518.90
Gross Income
9,306.00
13,481.20
14,647.20
518.80
452.50
SG&A Expense
7,555.80
8,006.20
10,770.80
431.70
1,447.90
EBIT
1,732.60
5,470.90
3,149.00
7,892.60
675.90
Unusual Expense
2.20
-
68,290.70
66,225.40
25,582.60
Non Operating Income/Expense
10,751.40
5,441.70
17,838.40
-
7,380.00
Interest Expense
1,699.40
1,809.20
2,222.60
770.40
498.50
Pretax Income
11,259.80
9,308.50
87,278.40
81,155.40
32,119.70
Income Tax
3,768.50
855.70
3,177.40
1,089.60
264.40
Consolidated Net Income
7,491.30
8,452.70
84,101.10
80,065.80
31,855.30
Net Income
6,445.60
4,949.90
82,588.50
80,065.80
31,855.30
Net Income After Extraordinaries
6,445.60
4,949.90
82,588.50
80,065.80
31,855.30
Net Income Available to Common
6,445.60
4,949.90
82,588.50
80,065.80
31,855.30
EPS (Basic)
0.17
0.12
1.93
1.87
0.74
Basic Shares Outstanding
38,596.60
41,275.10
42,813.80
42,813.80
42,813.80
EPS (Diluted)
0.17
0.12
1.93
1.87
0.74
Diluted Shares Outstanding
38,596.60
41,275.10
42,813.80
42,813.80
42,813.80
EBITDA
3,454.10
7,299.70
7,638.80
7,917.40
654.50
Other Operating Expense
17.60
4.10
727.40
8,843.00
1,224.60
Non-Operating Interest Income
477.40
205.10
222.90
7,807.90
331.60
Minority Interest Expense
1,045.70
3,502.90
1,512.60
-
-

About MPH Mittelstaendische Pharma Holding

View Profile
Address
Grünauer Strasse 5
Berlin Berlin 12557
Germany
Employees -
Website http://mph-ag.de
Updated 07/08/2019
MPH Health Care AG engages in the acquisition and development of companies and shares in companies from the healthcare industry. It focuses on the market of patent-free and patent-protected pharmaceuticals. The company was founded on November 11, 2008 and is headquartered in Berlin, Germany.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.